Red cell membrane and erythropoiesis genetic defects

Hematology Journal

Volumn 4, Issue 4, 2003, Pages 225-232

  Delaunay, Jean ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

Genetic disorders; Red cell membrane; Supramolecular organization

Indexed keywords

CODANIN 1; GLYPICAN; LIPID; MEMBRANE PROTEIN; MONOVALENT CATION; MULTIENZYME COMPLEX; UNCLASSIFIED DRUG;

ANEMIA; BLOOD GROUP RHESUS SYSTEM; COMPLEX FORMATION; DYSERYTHROPOIESIS; ERYTHROCYTE MEMBRANE; GAS TRANSPORT; GENE IDENTIFICATION; GENE MAPPING; GENE MUTATION; HUMAN; HYPERKALEMIA; INHERITANCE; ION PERMEABILITY; MEDICAL RESEARCH; MEMBRANE PERMEABILITY; NONHUMAN; REVIEW; STOMATOCYTOSIS;

ANEMIA, HEMOLYTIC, CONGENITAL; ANIMALS; ERYTHROCYTE MEMBRANE; ERYTHROPOIESIS; HUMANS; MEMBRANE PROTEINS; MUTATION;

EID: 0041522823     PISSN: 14664860     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.thj.6200255     Document Type: Review

References (64)

1. Gallagher PG, Forget B. Hematological important mutations: band 3 and protein 4.2 in hereditary spherocytosis. Blood Cells Mol Dis 1997; 23: 417-421 (Review).
2. Gallagher PG, Forget BG. Hematological important mutations: spectrin and ankyrin variants in hereditary spherocytosis. Blood Cells Mol Dis 1998; 24: 539-543 (Review).
3. Delaunay J. Molecular basis of red cell membrane disorders. In: Hitoshi Kanno (ed). Current Topic in Molecular Basis of Red Cell Disorder. Acta Haematol. Karger: Basel. 2002; 108: 10-218 (Review).
4. Delaunay J. Inherited abnormalities of the red cell membrane. In: Wickramasinghe SN, McCullough J (eds). Blood and Bone Marrow Pathology. Hartcourt Health Sciences: London, UK, 2003, pp 141-147 (Review).
5. Toye AM, Bruce LJ, Unwin RJ, Wrong O, Tanner MJ. Band 3 Walton, a C-terminal deletion associated with distal renal tubular acidosis, is expressed in the red cell membrane but retained internally in kidney cells. Blood 2002; 99: 342-347.
6. Dhermy D, Galand C, Bournier O, M-J King, Cynober T, Roberts I et al. Coinheritance of α- and β-spectrin gene mutations in a case of hereditary elliptocytosis. Blood 1998; 92: 4481-4482 (Correspondence).
7. Basseres DS, Vicentim DL, Costa FF, Saad STO, Hassoun H. Beta-spectrin Promissão: a translation initiation codon mutation of the beta-spectrin gene (ATG-to-GTG) associated with hereditary spherocytosis and spectrin deficiency in a Brazilian family. Blood 1998; 91: 368-369 (Letter).
8. Wichterle H, Hanspal M, Palek J. Jarolim P. Combination of two mutant alpha spectrin alleles underlies a severe spherocytic hemolytic anemia. J Clin Invest 1996; 98: 2300-2307.
9. Boulanger L, Sabatino DE, Wong EY, Cline AP, Garrett LJ, Garbarz M et al. Erythroid expression of the human alpha-spectrin gene promoter is mediated by GATA-1- and NF-E2-binding proteins. J Biol Chem 2002; 277: 41563-41570.
10. Gallagher PG, Sabatino DE, Basseres DS, Nilson DM, Wong C, Cline AP et al. Erythrocyte ankyrin promoter mutations associated with recessive hereditary spherocytosis cause significant abnormalities in ankyrin expression. J Biol Chem 2001; 276: 41683-41689.
11. Wandersee NJ, Birkenmeier CS, Gifford EJ, Narla M, Barker JA. Murine recessive hereditary spherocytosis, sph/sph, is caused by a mutation in the erythoid α-spectrin gene. Hematol J 2000; 1: 235-242.
12. Wandersee NJ, Roesch AM, Hamblen NR, de Moes J, van der Valk MA, Bronson RT et al. Defective spectrin integrity and neonatal thrombosis in the first mouse model for severe hereditary elliptocytosis. Blood 2001; 97: 543-550.
13. Wandersee NJ, Birkenmeier CS, Bodine DM, Narla M, Barker J. Mutations in the murine erythroid α-spectrin gene alter mRNA and protein levels and spectrin incorporation into the red blood cell membrane skeleton. Blood 2003; 101: 325-330.
14. Bloom ML, Kaysser TM, Birkenmeier CS, Barker JE. The murine mutation jaundiced is caused by replacement of an arginine with a stop codon in the mRNA encoding the ninth repeat of β-spectrin. Proc Natl Acad Sci USA 1994; 91: 10099-10103.
15. Birkenmeier C, Gifford EJ, Barker JE. The murine hereditary spherocytosis, normoblastosis, is caused by a single base deletion in the erythroid ankyrin gene and produces a partially functional truncated ankyrin. Blood 2000; 96(Suppl 1): 594 (Abstract).
16. -/-) suggests the presence of genetic modifiers of band 3 function in red blood cells. Blood 1998; 92(Suppl 1): 301a (Abstract).
17. Hassoun H, Wang Y, Vassiliadis J, Lutchman M, Palek J, Aish L et al. Targeted inactivation of murine band 3 (AE1) gene produces a hypercoagulable state causing widespread thrombosis in vivo. Blood 1998; 92: 1785-1792.
18. Southgate CD, Chishti AH, Mitchell B, Yi SJ, Palek J. Targeted disruption of the murine erythroid band 3 gene results in spherocytosis and severe haemolytic anaemia despite a normal membrane skeleton. Nat Genet 1996; 14: 227-230.
19. Peters LL, Shivdasani RA, Liu SC, Hanspal M, John KM, Gonzalez JM et al. Anion exchanger 1 (Band 3) is required to prevent erythrocyte surface loss but not to form the membrane skeleton. Cell 1996; 86: 917-927.
20. Paw BH. Cloning of the zebrafish retsina blood mutation: a genetic model for dyserythropoiesis and erythroid cytokinesis. Blood Cells Mol Dis 2001; 27: 62-64.
21. Shafizadeh E, Paw BH, Foott H, Liao EC, Barut BA, Cope JJ et al. Characterization of zebrafish merlot/chablis as non-mammalian vertebrate models for severe congenital anemia due to protein 4.1 deficiency. Development 2002; 129: 4359-4370.
22. Liao EC, Paw BH, Peters LL, Zapata A, Pratt SJ, Do CP et al. Hereditary spherocytosis in zebrafish riesling illustrates evolution of erythroid beta-spectrin structure, and function in red cell morphogenesis and membrane stability. Development 2000; 127: 5123-5132.
23. Han BG, Nunomura W, Wu H, Mohandas N, Jap BK. Crystallization and preliminary X-ray crystallographic analysis of the 30 kDa membrane-binding domain of protein 4.1 from human erythrocytes. Acta Crystallogr D Biol Crystallogr 2000; 56: 187-188.
24. Zhang D, Kiyatkin A, Bolin JT, Low PS. Crystallographic structure and functional interpretation of the cytoplasmic domain of erythrocyte membrane band 3. Blood 2000; 96: 2925-2933.
25. Low PS, Zhang D, Bolin JT. Localization of mutations leading to altered cell shape and anion transport in the crystal structure of the cytoplasmic domain of band 3. Blood Cells Mol Dis 2001; 27: 81-84.
26. Bruce LJ, Ghosh S, King MJ, Layton DM, Mawby WJ, Stewart GW et al. Absence of CD47 in protein 4.2-deficient hereditary spherocytosis in man: an interaction between the Rh complex and the band 3 complex. Blood 2002; 100: 1878-1885.
27. Mouro-Chanteloup I, Delaunay J, Gane P, Nicolas V, Johansen M, Brown EJ et al. Evidence that CD47 and protein 4.2 participate in the linkage of the Rh membrane complex to the red cell skeleton. Blood 2003; 101: 338-344.
28. Peters LL, Jindel HK, Gwynn B, Korsgren C, John KM, Lux SE. et al. Mild spherocytosis and altered red cell ion transport in protein 4.2-null mice. J Clin Invest 1999; 103: 1527-1537.
29. Lindberg FP, Bullard DC, Caver TE, Gresham HD, Beaudet AL, Brown EJ. Decreased resistance to bacterial infection and granulocyte defects in IAP-deficient mice. Science 1996; 274: 795-798.
30. Ribeiro L, Alloisio N, Almeida H, Gomes C, Texier P, Lemos C et al. Near lethal hereditary spherocytosis and distal tubular acidosis associated with the total absence of band 3. Blood 2000; 96: 1602-1604.
31. Bruce LJ, Beckmann R, Ribeiro ML, Peters LL, Chasis JA, Delaunay J et al. Evidence for a band 3-based membrane macrocomplex: a potential gas exchange metabolon. Blood (epub ahead of print, January 16, 2003).
32. Kuchay SM, Azam M, Chishti AH. The guanylate kinase-like domain of human erythrocyte membrane p55 interacts with the carboxyl-terminus of protein 4.2. Blood 2001; 98(Suppl 1): 9a. (Abstract).
33. Bordin L, Brunati AM, Donella-Deana A, Baggio B, Toninello A, Clari G. Band 3 is an anchor protein and a target for SHP-2 tyrosine phosphatase in human erythrocytes. Blood 2002; 100: 276-282.
34. Cartron JP. RH blood group system and molecular basis of Rh-deficiency. Baillires Best Pract Res Clin Haematol 1999; 12: 655-689 (Review).
35. Tamary H, Shalmon L, Shalev H, Halil A, Dobrushin D, Ashkenazi N et al. Localisation of the gene for congenital dyserythropietic anemia type I to a < 1-cM interval to chromosome 15q15.1-15.3. Am J Hum Genet 1998; 62: 1062-1069.
36. Dgany O, Avidan N, Delaunay J, Krasnov T, Shalmon L, Shalev H et al. Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1. Am J Human Genet 2002; 71: 1467-1474.
37. Lavabre-Bertrand T, Blanc P, Navarro R, Saghroun M, Vannereau H, Braun M et al. Alpha-interferon therapy for congenital dyserythropeiesis type I. Br J Haematol 1995; 89: 929-932.
38. Parez N, Dommergues M, Zupan V, Chambost H, Fieschi JB, Delaunay J et al. Severe congenital dyserythropoietic anaemia type 1: prenatal management, transfusion support and alpha-interferon therapy. Br J Haematol 2000; 110: 420-423.
39. Roda L, Pasche J, Fournier A, Terorotua V, Wickramasinghe SN, Tamary H et al. Congenital dyserythropoietic anemia, type 1, in a polynesian patient: response to interferon alpha2b. J Pediatr Hematol/Oncol 2002; 24: 503-506.
40. Freiberg AS, Gocke CD. Recombinant α-interferon (rIFNα) therapy for congenital dyserythropoietic anemia type I. Blood 1998; 92(Suppl 1): 16b (Abstract 3043).
41. Delaunay J, Iolascon A. The congenital dyserythropoietic anaemias. Ballieres Best Practice Res Clin Haematol 1999; 12: 691-705 (Review).
42. Gasparini P, Miraglia del Giudice E, Delaunay J, Totaro A, Granatiero M, Melchionda M et al. Localization of congenital dyserythropoietic anemia II (CDA II) locus to chromosome 20 (20q11.2) by genomewide search. Am J Hum Genet 1997; 61: 1112-1116.
43. Iolascon A, Miraglia del Giudice E, Perrotta S, Granatiero M, Zelante L, Gasparini P. Exclusion of three candidate genes as determinants of congenital dyserythropoietic anemia Type II (CDA II). Blood 1997; 90: 4197-4200.
44. Aebi M, Hennet T. Congenital disorders of glycosylation: genetic model systems lead the way. Trends Cell Biol 2001; 11: 136-141 (Review).
45. Zdebska E, Bader-Meunier, Schischmanoff PO, Dupré T, Seta N, Tchernia G et al. Abnormal glycosylation of red cell membrane band 3 in congenital disorder of glycosylation Ig. Pediatr Res (epub ahead of print, May 7, 2003).
46. Zdebska E, Musielak M, Jaeken J, Kościelak J. Band 3 glycoprotein and glycophorin A from erythrocytes of children with congenital disorder of glycosylation type Ia are underglycosylated. Proteomics 2001; 1: 269-274.
47. Charuk JHM, Tan J, Bernardini M, Haddad S, Reithmeier RAF, Jaeken J et al. Carbohydrate-deficient glycoprotein syndrome type II. An autosomal recessive N-acetylglucosaminyl transferase II deficiency different from typical hereditary erythroblastic multinuclearity, with a positive acidified serum lysis test (HEMPAS). Eur J Biochem 1995; 230: 797-805.
48. Delaunay J, Stewart G, Iolascon A. Hereditary dehydrated and overhydrated stomatocytosis: recent advances. Curr Opin Hematol 1999; 6: 110-114 (Review).
49. Zhu Y, Paszty C, Turetky T, Tsai S, Kuypers FA, Lee G et al. Stomatocytosis is absent in 'stomatin'-deficient murine red blood cells. Blood 1999; 93: 2404-2410.
50. Carella M, Stewart G, Ajetunmobi JF, Perrotta S, Grootenboer S, Tchernia G et al. Genomewide search for dehydrated hereditary stomatocytosis (hereditary xerocytosis): mapping of locus to chromosome 16 (16q23-qter). Am J Hum Genet 1998; 63: 810-816.
51. Iolascon A, Stewart G, Ajetunmobi JF, Perrotta S, Delaunay J, Carella et al. Familial pseudohyperkalemia maps to the same locus as dehydrated hereditary stomatocytosis (hereditary xerocytosis). Blood 1999; 93: 3120-3123.
52. Carella M, Stewart GW, Ajetunmobi JF, Schettini Jr F. Delaunay J, Iolascon A. Genetic heterogeneity of hereditary stomatocytosis syndromes showing pseudohyperkalemia. Haematologica 1999; 8: 862-863 (Letter).
53. Coles SE, Chetty MC, Ho MM, Nicolaou A, Kearney JW, Wright SD et al. Two British families with variants on the 'cryohyrocytosis' form of hereditary stomatocytosis. Br J Haematol 1999; 105: 1055-1065.
54. Haines PG, Jarvis HG, King S, Noormohamed FH, Chetty MC, Fisher J et al. Two further British families with the 'cryohydrocytosis' form of hereditary stomatocytosis. Br J Haematol 2001; 113: 932-937.
55. Haines PG, Crawley C, Chetty M, Jarvis H, Coles SE, Fisher J et al. Familial pseudohyperkalaemia Chiswick: a novel congenital thermotropic variant of K and Na transport across the human red cell membrane. Br J Haematol 2001; 112: 469-474.
56. Gore DM, Chetty MC, Fisher J, Nicolaou A, Stewart GW. Familial pseudohyperkalaemia Cardiff: a mild version of cryohydrocytosis. Br J Haematol 2002; 117: 212-214.
57. Grootenboer S, Schischmanoff PO, Laurendeau I, Cynober T, Tchernia G, Dommergues et al. Pleiotropic syndrome of dehydrated hereditary stomatocytosis, pseudohyperkalemia and perinatal edema maps to 16q23-q24. Blood 2000; 96: 2599-2605.
58. Grootenboer S, Barro C, Cynober C, Schischmanoff PO, Ayoubi JM, Tchernia G et al. Dehydrated hereditary stomatocytosis: a cause of prenatal edema. Prenat Diagn 2001; 21: 1114-1118.
59. Basu AP, Carey P, Cynober T, Chetty M, Delaunay J, Stewart GW et al. Dehydrated hereditary stomatocytosis with transient perinatal ascites. Arch Dis Child (in press).
60. Stewart GW, Amess JAL, Eber SW, Kingswood C, Lane PA, Smith BD et al. Thrombo-embolic disease after splenectomy for hereditary stomatocytosis. Br J Haematol 1996; 93: 303-310.
61. Brown DA, London E. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem 2000; 275: 17221-17224 (Review).
62. Salzer U, Prohaska R. Stomatin, flotillin-1 and flotillin-2 are major integral proteins of erythrocyte lipids rafts. Blood 2001; 97: 1141-1143.
63. 2+-dependent vesicles release from erythrocytes involves stomatin-specific lipid rafts, synexin (annexin VII), and sorcin. Blood 2002; 99: 2569-2577.
64. Whitlow M, Iida K, Marshall P, Silber P, Nussenzweig V. Cells lacking glycan phosphatidylinositol-linked proteins have impaired ability to vesiculate. Blood 1993; 81: 31-39.